Skip to main content

Find Clinical Trials

Home
Conditions
Melanoma

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

1,012 public trials 175 recruiting studies

Refine in advanced search Browse all conditions

Melanoma trial results

Not Yet Recruiting

XP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 Mutation

NCT05275374

Conditions: BRAF V600 Mutation, Bronchial Neoplasms, Cancer, +36 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase I/ II Study of Fragmented Autoantigen Stimulated T-cell-immunotherapy Combined with Radiotherapy (FAST-CR)

NCT06756295

Conditions: Breast Cancer, Colorectal Cancer, Breast Diseases, Breast Neoplasms, +27 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Statins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosis

NCT06785974

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +15 more
Locations: Erasmus Universitair Medisch Cetrum Rotterdam Rotterdam, South Holland, Netherlands

View Trial Details

Not Yet Recruiting

Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)

NCT06683755

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Not Yet Recruiting

Gene Expression Profiles and ctDNA for Risk Stratification in Patients With Melanoma

NCT06566404

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors

NCT06500091

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +12 more
Locations: Cancer Hospital Chinese Academy of Medical Science Beijing, Beijing Municipality, China

Beijing Cancer Hospital Beijing, Beijing Municipality, China

Henan Cancer Hospital Affiliated Cancer Hospital of Zhengzhou University Zhengzhou, Henan, China

Hunan Cancer Hospital Changsha, Hunan, China

View Trial Details

Not Yet Recruiting

Circulating Tumour DNA Guided Adaptive BRAF and MEK Inhibitor Therapy

NCT06470880

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure

NCT06327698

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma

NCT06212388

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Interferon-α1b Combined With Toripalimab and Anlotinib Hydrochloride in Advanced Unresectable Melanoma

NCT05539118

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Air Force Military Medical University/ Fourth Military Medical University Xi'an, Shaanxi, China

View Trial Details